← Eichor
Study identifier: NCT05996159 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation

Condition: Paroxysmal Atrial Fibrillation  ·  Sponsor: Seoul National University Hospital

PhaseNA
Planned participants150
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersNo

About this study

This study aims to investigate the effect of reducing ablation time for a hybrid approach of vHPSD and AI-guided ablation using the QDOT Micro catheter in PVI among patients with PAF.

This description comes directly from the study's public registry record.

Talk to the study team

Eue-Keun Choi, M.D. Ph.D.  ·  82-2-2072-0688  ·  choiek417@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Seoul National University HospitalSeoul, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05996159